What is the current valuation of the US bone implant market as of 2024?

The US bone implant market was valued at $1200.0 Million in 2024. Read More

What is the projected market valuation for the US bone implant market in 2035?

The projected valuation for the US bone implant market in 2035 is $4000.0 Million. Read More

What is the expected CAGR for the US bone implant market during the forecast period 2025 - 2035?

The expected CAGR for the US bone implant market during the forecast period 2025 - 2035 is 11.57%. Read More

Which companies are considered key players in the US bone implant market?

Key players in the US bone implant market include Stryker Corporation, Zimmer Biomet Holdings Inc, DePuy Synthes, Medtronic plc, Smith & Nephew plc, NuVasive Inc, Amedica Corporation, and Orthofix Medical Inc. Read More

What are the main segments of the US bone implant market?

The main segments of the US bone implant market include biomaterials, products, applications, devices, and end-users. Read More

What was the valuation range for orthopedic screws in the US bone implant market?

The valuation range for orthopedic screws in the US bone implant market was between $300.0 Million and $1000.0 Million. Read More

How do the valuations of hip orthopedic implants compare to knee orthopedic implants?

Hip orthopedic implants were valued between $240.0 Million and $800.0 Million, whereas knee orthopedic implants had a valuation range of $300.0 Million to $1000.0 Million. Read More

What is the valuation range for internal fixators in the US bone implant market?

The valuation range for internal fixators in the US bone implant market is between $900.0 Million and $3000.0 Million. Read More

Which end-user segment had the highest valuation in the US bone implant market?

The hospitals segment had the highest valuation in the US bone implant market, ranging from $720.0 Million to $2400.0 Million. Read More

What is the projected growth trend for the ceramics segment in the US bone implant market?

The ceramics segment in the US bone implant market is projected to grow, with a valuation range of $600.0 Million to $2000.0 Million. Read More

US Bone Implant Market

ID: MRFR/MED/17454-HCR

100 Pages

Satyendra Maurya

Last Updated: April 06, 2026

US Bone Implant Market Research Report By Biomaterial (metals, titanium, stainless steel, cobalt chromium alloy, gold alloys, tantalum, ceramics, alumina, hydroxyapatite, beta-tricalcium phosphate, bioglass, carbon, zirconia, zirconia-toughened alumina, polymers, polymethylmethacrylate, polytetrafluoroethylene, polyethylene, polysulfone, polyurethane, polyether ether ketone), By Product (orthopedic screws, orthopedic plates, interlocking nails (rods), others), By Application (hip orthopedic implants, knee orthopedic implants, spine orthopedic implants, dental orthopedic implants, others), By Device (external fixators, internal fixators) and By End User (orthopedic clinics, hospitals, others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Biomaterial (USD Million)
  1. 4.1.1 Metals
  2. 4.1.2 Ceramics
  3. 4.1.3 Polymers
2. 4.2 Pharmaceutical, BY Product (USD Million)
  1. 4.2.1 Orthopedic Screws
  2. 4.2.2 Orthopedic Plates
  3. 4.2.3 Interlocking Nails (Rods)
  4. 4.2.4 Others
3. 4.3 Pharmaceutical, BY Application (USD Million)
  1. 4.3.1 Hip Orthopedic Implants
  2. 4.3.2 Knee Orthopedic Implants
  3. 4.3.3 Spine Orthopedic Implants
  4. 4.3.4 Dental Orthopedic Implants
  5. 4.3.5 Others
4. 4.4 Pharmaceutical, BY Device (USD Million)
  1. 4.4.1 External fixators
  2. 4.4.2 Internal fixators
5. 4.5 Pharmaceutical, BY End-User (USD Million)
  1. 4.5.1 Orthopedic clinics
  2. 4.5.2 Hospitals
  3. 4.5.3 Others
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Stryker Corporation (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Zimmer Biomet Holdings Inc (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 DePuy Synthes (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Medtronic plc (IE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Smith & Nephew plc (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 NuVasive Inc (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Amedica Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Orthofix Medical Inc (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY BIOMATERIAL
3. 6.3 US MARKET ANALYSIS BY PRODUCT
4. 6.4 US MARKET ANALYSIS BY APPLICATION
5. 6.5 US MARKET ANALYSIS BY DEVICE
6. 6.6 US MARKET ANALYSIS BY END-USER
7. 6.7 KEY BUYING CRITERIA OF PHARMACEUTICAL
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF PHARMACEUTICAL
10. 6.10 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
12. 6.12 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
13. 6.13 PHARMACEUTICAL, BY BIOMATERIAL, 2024 (% SHARE)
14. 6.14 PHARMACEUTICAL, BY BIOMATERIAL, 2024 TO 2035 (USD Million)
15. 6.15 PHARMACEUTICAL, BY PRODUCT, 2024 (% SHARE)
16. 6.16 PHARMACEUTICAL, BY PRODUCT, 2024 TO 2035 (USD Million)
17. 6.17 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
18. 6.18 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
19. 6.19 PHARMACEUTICAL, BY DEVICE, 2024 (% SHARE)
20. 6.20 PHARMACEUTICAL, BY DEVICE, 2024 TO 2035 (USD Million)
21. 6.21 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
22. 6.22 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY BIOMATERIAL, 2025-2035 (USD Million)
  2. 7.2.2 BY PRODUCT, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY DEVICE, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Biomaterial (USD Million, 2025-2035)

Metals
Ceramics
Polymers

Pharmaceutical By Product (USD Million, 2025-2035)

Orthopedic Screws
Orthopedic Plates
Interlocking Nails (Rods)
Others

Pharmaceutical By Application (USD Million, 2025-2035)

Hip Orthopedic Implants
Knee Orthopedic Implants
Spine Orthopedic Implants
Dental Orthopedic Implants
Others

Pharmaceutical By Device (USD Million, 2025-2035)

External fixators
Internal fixators

Pharmaceutical By End-User (USD Million, 2025-2035)

Orthopedic clinics
Hospitals
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”